National Cancer Institute Awards $1.4M Phase II SBIR Grant to Cynvenio…

Phase II award will fund development of novel microfluidic platform for aptamer discovery.

(PRWeb July 31, 2012)

Read the full story at http://www.prweb.com/releases/2012/7/prweb9757330.htm


Comments are closed.